Filing Details

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D/A

(Rule 13d-101)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED

PURSUANT TO RULE 13d-2(a)

Under the Securities Exchange Act of 1934

(Amendment No. 1)*

Anaplan, Inc.

(Name of Issuer)

Common Stock, par value $0.0001 per share

(Title of Class of Securities)

03272L108

(CUSIP Number)

Michael D. Adamski

Sachem Head Capital Management LP

250 West 55th Street, 34th Floor

New York, New York 10019

(212) 714-3300

With a copy to:

Richard M. Brand

Cadwalader, Wickersham & Taft LLP

200 Liberty Street

New York, NY 10281

212-504-6000

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

March 21, 2022

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box. ☐ 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

This Amendment No. 1 (this “Amendment”) amends and supplements the Schedule 13D filed on March 17, 2022 (the “Schedule 13D) by the Reporting Persons relating to their beneficial ownership in Anaplan, Inc. (the “Issuer”). Except to the extent set forth in this Amendment, all information disclosed in the Schedule 13D remains unchanged. Capitalized terms used but not defined in this Amendment have the respective meanings set forth in the Schedule 13D.

The information set forth in response to each separate item below shall be deemed to be a response to all items where such information is relevant. The Schedule 13D is hereby amended as follows:

Item 4 of the Schedule 13D is hereby amended to add the following:

On March 21, 2022, the Advocacy Agreement was terminated, effective immediately.  Accordingly, the Reporting Persons are no longer members of a Section 13(d) group with Corvex and each of the Reporting Persons expressly disclaims beneficial ownership of any shares of Common Stock held by Corvex.

Responses to Item 5 and 6 are incorporated herein by reference.

Item 5 of the Schedule 13D is hereby amended to add the following:

On March 21, 2022, the Advocacy Agreement was terminated, effective immediately.  Accordingly, the Reporting Persons are no longer members of a Section 13(d) group with Corvex and each of the Reporting Persons expressly disclaims beneficial ownership of any shares of Common Stock held by Corvex. Upon the termination of the Advocacy Agreement, the Reporting Persons are beneficial owners of less than 5% of the Issuer’s Common Stock and are therefore not subject to the reporting obligations under Section 13(d) of the Act.

Item 6 of the Schedule 13D is hereby amended to add the following:

On March 21, 2022, the Advocacy Agreement was terminated, effective immediately.  Accordingly, the Reporting Persons are no longer members of a Section 13(d) group with Corvex and each of the Reporting Persons expressly disclaims beneficial ownership of any shares of Common Stock held by Corvex.

SIGNATURES

After reasonable inquiry and to the best of each of the undersigned’s knowledge and belief, each of the undersigned certify that the information set forth in this statement is true, complete and correct.

 

Date: March 21, 2022

	SACHEM HEAD CAPITAL MANAGEMENT LP
	By:	Uncas GP LLC, its General Partner
	By:	/s/ Scott D. Ferguson
		Name:  Scott D. Ferguson
		Title:     Managing Member

---